HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 286/2/C283    most recent 00319.2003v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (17) Citing Articles via Google Scholar Google Scholar Articles by Yu, H. Articles by Goodyear, L. J. Search for Related Content PubMed PubMed Citation Articles by Yu, H. Articles by Goodyear, L. J.

MUSCLE CELL BIOLOGY AND CELL MOTILITY

Cloning and characterization of mouse 5'-AMP-activated protein kinase 3 subunit

Research Division, Joslin Diabetes Center, and Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02215

Submitted 25 July 2003 ; accepted in final form 17 September 2003

Naturally occurring mutations in the regulatory -subunit of 5'-AMP-activated protein kinase (AMPK) can result in pronounced pathological changes that may stem from increases in muscle glycogen levels, making it critical to understand the role(s) of the -subunit in AMPK function. In this study we cloned the mouse AMPK3 subunit and revealed that there are two transcription start sites, which result in a long form, 3L (AF525500) and a short form, 3S (AF525501). AMPK3L is the predominant form in mouse and is specifically expressed in mouse skeletal muscle at the protein level. In skeletal muscle, AMPK3 shows higher levels of expression in fast-twitch white glycolytic muscle (type IIb) compared with fast-twitch red oxidative glycolytic muscle (type IIa), whereas 3 is undetectable in soleus muscle, a slow-twitch oxidative muscle with predominantly type I fibers. AMPK3 can coimmunoprecipititate with both and AMPK subunits. Overexpression of 3S and 3L in mouse tibialis anterior muscle in vivo has no effect on 1 and 2 subunit expression and does not alter AMPK2 catalytic activity. However, 3S and 3L overexpression significantly increases AMPK1 phosphorylation and activity by 50%. The increase in AMPK1 activity is not associated with alterations in glycogen accumulation or glycogen synthase expression. In conclusion, the 3 subunit of AMPK is highly expressed in fast-twitch glycolytic skeletal muscle, and wild-type 3 functions in the regulation of 1 catalytic activity, but it is not associated with changes in muscle glycogen concentrations.

adenosine 5'-monophosphate-activated protein kinase; AMPK3 short form; AMPK3 long form; cystathionine -synthase domain

This article has been cited by other articles:

				V. W. Dolinsky and J. R. B. Dyck Role of AMP-activated protein kinase in healthy and diseased hearts Am J Physiol Heart Circ Physiol, December 1, 2006; 291(6): H2557 - H2569. [Abstract] [Full Text] [PDF]

				H.-J. Koh, D. E. Arnolds, N. Fujii, T. T. Tran, M. J. Rogers, N. Jessen, Y. Li, C. W. Liew, R. C. Ho, M. F. Hirshman, et al. Skeletal Muscle-Selective Knockout of LKB1 Increases Insulin Sensitivity, Improves Glucose Homeostasis, and Decreases TRB3 Mol. Cell. Biol., November 15, 2006; 26(22): 8217 - 8227. [Abstract] [Full Text] [PDF]

				H. Yu, M. F. Hirshman, N. Fujii, J. M. Pomerleau, L. E. Peter, and L. J. Goodyear Muscle-specific overexpression of wild type and R225Q mutant AMP-activated protein kinase {gamma}3-subunit differentially regulates glycogen accumulation Am J Physiol Endocrinol Metab, September 1, 2006; 291(3): E557 - E565. [Abstract] [Full Text] [PDF]

				S. B. Jorgensen, E. A. Richter, and J. F. P. Wojtaszewski Role of AMPK in skeletal muscle metabolic regulation and adaptation in relation to exercise J. Physiol., July 1, 2006; 574(1): 17 - 31. [Abstract] [Full Text] [PDF]

				A. Sriwijitkamol, J. L. Ivy, C. Christ-Roberts, R. A. DeFronzo, L. J. Mandarino, and N. Musi LKB1-AMPK signaling in muscle from obese insulin-resistant Zucker rats and effects of training Am J Physiol Endocrinol Metab, May 1, 2006; 290(5): E925 - E932. [Abstract] [Full Text] [PDF]

				J. W. Ryder, Y. C. Long, E. Nilsson, M. Mahlapuu, and J. R. Zierath Effects of calcineurin activation on insulin-, AICAR- and contraction-induced glucose transport in skeletal muscle J. Physiol., September 1, 2005; 567(2): 379 - 386. [Abstract] [Full Text] [PDF]

				J. F. P Wojtaszewski, J. B Birk, C. Frosig, M. Holten, H. Pilegaard, and F. Dela 5'AMP activated protein kinase expression in human skeletal muscle: effects of strength training and type 2 diabetes J. Physiol., April 15, 2005; 564(2): 563 - 573. [Abstract] [Full Text] [PDF]

				R. Pold, L. S. Jensen, N. Jessen, E. S. Buhl, O. Schmitz, A. Flyvbjerg, N. Fujii, L. J. Goodyear, C. F. Gotfredsen, C. L. Brand, et al. Long-Term AICAR Administration and Exercise Prevents Diabetes in ZDF Rats Diabetes, April 1, 2005; 54(4): 928 - 934. [Abstract] [Full Text] [PDF]